CA-ALTIUM-LLC
4.6.2020 09:02:08 CEST | Business Wire | Press release
From home offices to virtual workplaces, the working environment has changed. For the Printed Circuit Board (PCB) design industry, Altium has helped make the transition seamless, empowering collaboration across every aspect of the design process. With Altium 365, the world’s only cloud-based platform for PCB design and realization, many of Altium’s customers were able to stay in motion even during the most challenging times.
As the world gets back to business, Altium is making it easy for PCB designers to continue to work from anywhere and connect with anyone.
“The workplace is more distributed than ever before, and at the same time our customers are dealing with unprecedented financial challenges,” says Ted Pawela, Altium’s COO. “We want to help the industry get back on track by making it easier than ever before to get the tools they need for PCB design, and work collaboratively in distributed work environments.”
Coming Together Without Impacting Workflow
Altium’s newest cloud-based platform, Altium 365, creates a connected experience throughout the PCB development and manufacturing process, making it easy to share PCB designs and collaborate in real-time with anyone - in any time zone, at any company, from anywhere - as the design evolves.
The platform has proven to be essential for PCB designers worldwide, including the teams working on the Open Source Ventilator Project , a global coalition of engineers, designers and medical practitioners. With Altium 365, PCB designers were able to co-design with mechanical engineers, in real-time via an easy online platform to finalize the designs.
As Douglas Karnazes, Founder and CEO of Velocity Research and member of the Open Source Ventilator Project elaborates, ‘When you have 3,000 people working on a project, labor and software is unlimited; the only limitation is time. We needed close collaboration with this many people, working from all over the world, all working from home, and Altium 365 helped pull everyone together.”
Salt Lake City’s Cirris Systems adopted Altium 365 just before workspaces shifted from physical to virtual. The need for remote work options would have been overwhelming for Cirris System’s one-man IT department, but with Altium 365, the company was able to transition to remote work without the need for new servers, VPNs or any downtime.
As Orlan Thatcher, Board Layout Specialist at Cirrius Systems, elaborates, “Our electrical engineers and myself have been using Altium 365 every day from our homes to do everything from sharing designs to preserving tight revision and process controls, that our bigger aerospace and aviation clients now expect.”
Altium Designer users do not have to change the way they work today to take advantage of Altium 365. The PCB design team at SkyShips , a Tier One automotive manufacturer of Infotainment systems, is using Altium 365 to align the global engineering team during the entire development process.
“We use the Altium 365 workspaces as a way to keep all our components, designs and projects all in one place, so that everyone is working from the same source of information. We are able to design faster with teams at different locations, “ stated Chris Brawn, Senior Design Engineer at SkyShips.
Making PCB Design Tools Accessible for Everyone
Altium has rolled out several initiatives to keep the electronics industry moving forward, including aggressive pricing for Altium Designer perpetual licenses with Altium 365 subscriptions. Altium is also allowing customers to pay in installments over a 12-month period, for those customers whose businesses are strapped for cash.
The newly launched Altium Designer Refer-a-Friend Program is another exciting opportunity for users to share their passion for Altium’s tools with their friends and colleagues and be rewarded. This newly launched program allows users to refer colleagues to purchase Altium Designer via a unique referral link accessible for current Altium Designer customers. When used to purchase a new license of Altium Designer, participants earn cash rewards.
ABOUT ALTIUM
Altium LLC (ASX:ALU ), a global software company headquartered in San Diego, Calif., is accelerating the pace of innovation through electronics. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.
The growing demand for smart and connected products is driving advancements in electronics technology. Design trends are demonstrating the need for minimizing power, reducing package size and energy consumption, and prioritizing high-speed design. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers, from idea to board. Users are at the center of Altium’s R&D and business operations. With its unique Business-to-User approach, Altium is focused on developing software that is easy to use and implement, with solutions that enable innovation and deliver industry-leading user productivity. Products include Altium Designer® , Altium Concord Pro™, Altium 365® , Altium NEXUS® , CircuitMaker® , CircuitStudio® , Octopart® , and TASKING® . To learn more about Altium, visit www.altium.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200604005247/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
